These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2982630)

  • 1. Chediak-Higashi syndrome: studies in long-term bone marrow culture.
    Newburger PE; Speier C; Stock JL; Perrine SP; Greenberger JS
    Exp Hematol; 1985 Feb; 13(2):117-22. PubMed ID: 2982630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chediak-Higashi syndrome. Expression of the cytoplasmic defect by in vitro cultures of bone marrow progenitors.
    Barak Y; Karov Y; Nir E; Wagner Y; Kristal H; Levin S
    Am J Pediatr Hematol Oncol; 1986; 8(2):128-33. PubMed ID: 3740366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired microtubule function correctable by cyclic GMP and cholinergic agonists in the Chediak-Higashi syndrome.
    Oliver JM
    Am J Pathol; 1976 Nov; 85(2):395-418. PubMed ID: 187062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction of characteristic abnormalities of microtubule function and granule morphology in Chediak-Higashi syndrome with cholinergic agonists.
    Oliver JM; Zurier RB
    J Clin Invest; 1976 May; 57(5):1239-47. PubMed ID: 1262469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Granulocyte stem cells in a case of Chediak-Higashi-Steinbrinck syndrome].
    Parmentier C; Micheau C; Morardet N; Brossel-Morel S
    Biomedicine; 1975 Feb; 23(2):59-63. PubMed ID: 1156630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal bactericidal, metabolic, and lysosomal functions of Chediak-Higashi Syndrome leukocytes.
    Root RK; Rosenthal AS; Balestra DJ
    J Clin Invest; 1972 Mar; 51(3):649-65. PubMed ID: 4400956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Chédiak-Higashi syndrome. Evidence that defective leukotaxis is primarily due to an impediment by giant granules.
    Clawson CC; White JG; Repine JE
    Am J Pathol; 1978 Sep; 92(3):745-53. PubMed ID: 686156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinico-hematological profile of Chediak-Higashi syndrome: experience from a tertiary care center in south India.
    Roy A; Kar R; Basu D; Srivani S; Badhe BA
    Indian J Pathol Microbiol; 2011; 54(3):547-51. PubMed ID: 21934218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the analysis of the pathophysiology of Chediak-Higashi syndrome. Defects expressed by cultured melanocytes.
    Zhao H; Boissy YL; Abdel-Malek Z; King RA; Nordlund JJ; Boissy RE
    Lab Invest; 1994 Jul; 71(1):25-34. PubMed ID: 8041115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysosomal enzyme activities in Chediak-Higashi syndrome: evaluation of lymphoblastoid cell lines and review of the literature.
    Holcombe RF; Jones KL; Stewart RM
    Immunodeficiency; 1994; 5(2):131-40. PubMed ID: 8032365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocytochemical identification of azurophilic and specific granule markers in the giant granules of Chediak-Higashi neutrophils.
    Rausch PG; Pryzwansky KB; Spitznagel JK
    N Engl J Med; 1978 Mar; 298(13):693-8. PubMed ID: 75504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, molecular, and cell biological aspects of Chediak-Higashi syndrome.
    Introne W; Boissy RE; Gahl WA
    Mol Genet Metab; 1999 Oct; 68(2):283-303. PubMed ID: 10527680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autophagia in myeloid precursors: an explanation for neutropenia in Chediak-Higashi syndrome?
    Oberling F; Lang JM; Juif JG; Luckel JC
    Scand J Haematol; 1976 Aug; 17(2):105-10. PubMed ID: 968442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysosome enlargement in the Chediak-Higashi syndrome.
    Spicer SS; Sato A; Vincent R; Eguchi M; Poon KC
    Fed Proc; 1981 Apr; 40(5):1451-5. PubMed ID: 7215561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of cytotoxic T lymphocyte function in Chediak-Higashi syndrome arises from a secretory defect that prevents lytic granule exocytosis.
    Baetz K; Isaaz S; Griffiths GM
    J Immunol; 1995 Jun; 154(11):6122-31. PubMed ID: 7751653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chediak-Higashi syndrome. A laboratory finding].
    Ayuso C; Defain Tesoriero MV; Tissera G; Osta V; Bedroznik L
    Sangre (Barc); 1998 Oct; 43(5):426-9. PubMed ID: 9868336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective granulocyte chemotaxis in the Chediak-Higashi syndrome.
    Clark RA; Kimball HR
    J Clin Invest; 1971 Dec; 50(12):2645-52. PubMed ID: 4942966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chédiak-Higashi syndrome].
    van Eerdenburg FJ; Bouw J
    Tijdschr Diergeneeskd; 1985 May; 110(10):391-9. PubMed ID: 4012747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chediak-Higashi syndrome--a case report with ultrastructural and cytogenetic study.
    Yasha TS; Vani S; Vasanth A; Augustus M; Ramamohan Y; Das S; Shankar SK
    Indian J Pathol Microbiol; 1997 Jan; 40(1):75-9. PubMed ID: 9145619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysosomal enzymes in normal and Chediak-Higashi blood leukocytes.
    Kimball HR; Ford GH; Wolff SM
    J Lab Clin Med; 1975 Oct; 86(4):616-30. PubMed ID: 170348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.